Pubblicazioni

Paclitaxel and pazopanib in ovarian cancer

2018 - JAMA ONCOLOGY

Tomao, Federica; Benedetti Panici, Pierluigi; Tomao, Silverio

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.

2018 - JAMA ONCOLOGY

Cremolini, C; Antoniotti, C; Lonardi, S; Aprile, G; Bergamo, F; Masi, G; Grande, R; Tonini, G; Mescoli, C; Cardellino, Gg; Coltelli, L; Salvatore, L; Corsi, Dc; Lupi, C; Gemma, D; Ronzoni, M; Dell'Aquila, E; Marmorino, F; DI FABIO, Fabio; Mancini, Ml; Marcucci, L; Fontanini, G; Zagonel, V; Boni, L; Falcone, A

Findings linking mismatch repair mutation with age at endometrial and ovarian cancer onset in Lynch syndrome

2018 - JAMA ONCOLOGY

Bogani, G; Leone Roberti Maggiore, U; Lorusso, D; Raspagliesi, F.